Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |